AlphAIAlphAI — Financial news for AI agents
investing.com$CTVA

Corteva earnings missed by $0.04, revenue fell short of estimates

Corteva (CTVA) reported Q3 EPS of $0.06, missing estimates by $0.04, with revenue at $1.59B, below the $1.77B consensus. The company forecasts FY 2026 EPS of $0.76-$0.80, higher than the $0.60 analyst consensus. Shares are down over 80% in the last 12 months.

Original reporting
investing.com
Published Nov 11, 2026, 9:52 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2026, 10:07 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$CTVA
Bearish
high confidence
Mentioned
$CTVA
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CTVABearishHigh
01

Why it matters

The earnings miss may trigger short‑term sell pressure, but the guidance range remains above consensus, offering a possible support level.

02

Market read

The report provides fresh earnings data that can influence trading decisions on CTVA and related agritech stocks.

03

What to watch

Potential cost‑saving initiatives and upcoming product launches could mitigate the short‑term miss.

Relevance 8/10Novelty 8/10Timing: post-market today

Background

Corteva (NYSE: CTVA) is a major U.S. agricultural chemicals company that recently reported its Q3 results.

Company-level read

Ticker impact

$CTVABearishHigh confidence
Context

Corteva reported Q3 EPS of $0.06, missing estimates by $0.04 and revenue of $1.59B, below the $1.77B consensus.

Expected impact

likely downward pressure as the market prices in the earnings miss

Evidence & confidence

The miss is material and the guidance range is only modestly above consensus, offering limited upside.

Market effects

Sector

Agricultural chemicals sector may see broader pressure if Corteva's demand outlook signals a slowdown.

Regional

U.S. agribusiness investors could adjust exposure to related stocks.

Global

Limited; primarily affects U.S. listed agritech equities.

Counterpoint

What could challenge this read

Some investors may view the modest guidance as a floor and consider buying on the dip.

Key entities

  • Company
    Corteva

    U.S. agricultural chemicals producer.

Read at source← All news

Also covered by

3 outlets

Related articles

$CTVAHighAI 8/10

Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook

Corteva, Inc. (CTVA) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook • Third-quarter results reflect strong new product sales growth and continued operational excellence, helping mitigate broader market headwinds • Pricing pressure was concentrated in North America an

SEC EDGAR 8-K
$CTVAMed

Mizuho reiterates Corteva stock rating on challenging crop market

Mizuho reiterated an Outperform rating and $16.00 price target for Corteva Inc. (CTVA) after its latest results. The stock is undervalued at $12.14, with a market cap of $8.1 billion. Corteva reported a 17% YoY decline in EBITDA, with regional sales varying. The company reduced its 2026 EBITDA guidance due to challenging market conditions, particularly in Brazil. Q3 results missed expectations, with revenue down 9% YoY.

investing.com
$CTVAHighAI 8/10

Corteva shares fall 6% on worse-than-expected Q3 results

Corteva Inc. (CTVA) reported Q3 earnings of $0.06 per share, missing estimates of $0.10, and revenue of $1.59B, below the $1.77B forecast. Shares fell 6.4%. Full-year 2026 guidance adjusted, with EPS midpoint at $0.78, above consensus, but EBITDA guidance lowered due to Brazil market conditions. Revenue declined 9% YoY, with Latin America sales down 31% and North America up 7%.

investing.com
$CTVAHighAI 8/10

Why is Corteva stock sliding today?

Corteva stock fell 6.4% after reporting Q3 results below expectations, with net sales down 9% YoY and a GAAP loss of $54M. Adjusted EPS dropped 57% to $0.06. The company cited weak Latin America performance and revised 2026 guidance lower, citing Brazil market conditions. Analysts had already cut EPS estimates and price targets. The S&P 500 was flat, indicating the drop was company-specific.

investing.com
$CTVAHighAI 8/10

Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook

Corteva reported Q3 2026 results with net sales down 9% YoY to $1.59B, organic sales also down 9%. Adjusted EBITDA fell 17% to $222M. Full-year guidance was updated, reflecting weaker Brazil market conditions, with adjusted EBITDA now expected between $1.1B and $1.125B. CEO Luke Kissam cited strong new product performance and operational excellence.

prnewswire.com